Success Story: Statistics Researcher Earns I-140 NIW Approval for Advancing Clinical Trial Methodologies Despite RFE
Client’s Testimonial:
"I truly appreciate all your support in getting my application approved during such a difficult time. I didn’t expect the process to go this smoothly, and I’m very grateful.”
On June 8th 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Biostatistician II in the Field of Statistics (Approval Notice).
General Field: Statistics
Position at the Time of Case Filing: Biostatistician II
Country of Origin: China
State of Residence at the Time of Filing: New York
Approval Notice Date: June 8th, 2026
Processing Time: 6 months (Premium Processing Upgrade Requested)
Case Summary:
We are delighted to share the approval of our client’s I-140 National Interest Waiver (NIW) petition. The client holds a Ph.D. in applied mathematics and statistics and works as a biostatistician II, where she applies advanced statistical methods to clinical research. Her work focuses on designing and implementing sophisticated statistical methodologies that optimize clinical trials and complex healthcare data analyses, helping strengthen biomedical research infrastructure, accelerate the development of safe and effective therapies, and improve patient outcomes.
To establish the national importance of the client’s proposed endeavor, we demonstrated that rigorous statistical methodologies are fundamental to modern biomedical research. Rather than serving only a single institution, her research supports the broader healthcare ecosystem by improving the reliability of clinical trials, enhancing the use of large-scale medical datasets, and advancing data-driven approaches to therapeutic development. We also highlighted that her work aligns with national priorities in healthcare innovation and received support from the National Institute of Mental Health (NIMH), reinforcing the importance of continued research in this area.
We further showed that the client is well positioned to advance her proposed endeavor through a consistent record of scholarly achievement. She has authored 16 peer-reviewed journal articles and 15 conference abstracts, and her published work has been cited 123 times by researchers in the field. Rather than treating these numbers as standalone accomplishments, we explained that the citations reflected independent reliance on her statistical methods and findings in subsequent biomedical research. We also noted that several of her publications achieved strong citation performance relative to other papers published in the same year and field, providing additional context for the significance of her contributions.
The petition also emphasized the professional recognition the client has received within the research community. She has been invited to perform peer review for an academic journal, illustrating that other experts trust her judgment to evaluate scientific research. Although her formal peer review experience is still developing, we demonstrated that it complements a broader body of evidence showing her expertise in statistical modeling, machine learning, and clinical research.
By presenting a cohesive record of impactful research, scholarly publications, independent citations, research funding, and professional recognition, we demonstrated that the client is well positioned to continue advancing statistical methodologies that improve clinical trial design and healthcare data analysis. We congratulate the client on her I-140 NIW approval after receiving an RFE and look forward to her continued contributions to biomedical research and patient care in the United States.